🇧🇷 Ogen .625 in Brazil

Ogen .625 (estrone sulphate) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Ogen .625 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Brazil

Frequently asked questions

Is Ogen .625 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Ogen .625 in Brazil?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.